RNA-Seq Profiling Reveals Novel Hepatic Gene Expression Pattern in Aflatoxin B1 Treated Rats

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Merrick, B Alex ^a   Phadke, Dhiral P ^b   Auerbach, Scott S ^a   Mav, Deepak ^b   Stiegelmeyer, Suzy M ^b   Shah, Ruchir R ^b   Tice, Raymond R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SRA (Systems Research and Applications) International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AROMATIC HYDROCARBON RECEPTOR; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A7C; GLUTATHIONE; HEPATIC AFLATOXIN RESPONSIVE TRANSCRIPT 1; HEPATIC AFLATOXIN RESPONSIVE TRANSCRIPT 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CENTROMERE; CHEMICAL CARCINOGENESIS; CHROMOSOME 15Q; CHROMOSOME 1Q; CONTROLLED STUDY; EXON; EXTRACELLULAR MATRIX; G1 PHASE CELL CYCLE CHECKPOINT; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE REPLICATION; GENETIC VARIABILITY; LIVER CARCINOGENESIS; MALE; MICROARRAY ANALYSIS; MITOSIS SPINDLE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RAT; RNA PROBE; RNA SEQUENCE; RNA SPLICING; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; XENOBIOTIC METABOLISM;

AFLATOXIN B1; ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; E2F1 TRANSCRIPTION FACTOR; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GLUCURONOSYLTRANSFERASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; PRINCIPAL COMPONENT ANALYSIS; RATS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

RATTUS;

EID: 84876453615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061768     Document Type: Article

References (81)

1. Mardis ER, (2008) Next-generation DNA sequencing methods. Annual review of genomics and human genetics 9: 387-402.
2. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y, (2008) RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome research 18: 1509-1517.
3. Wang Z, Gerstein M, Snyder M, (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nature reviews Genetics 10: 57-63.
4. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature methods 5: 621-628.
5. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321: 956-960.
6. Chen H, Liu Z, Gong S, Wu X, Taylor WL, et al. (2011) Genome-Wide Gene Expression Profiling of Nucleus Accumbens Neurons Projecting to Ventral Pallidum Using both Microarray and Transcriptome Sequencing. Frontiers in neuroscience 5: 98.
7. Enoch MA, Zhou Z, Kimura M, Mash DC, Yuan Q, et al. (2012) GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naive P and NP rats. PloS one 7: e29369.
8. Neckar J, Silhavy J, Zidek V, Landa V, Mlejnek P, et al. (2012) CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis. Physiological genomics 44: 173-182.
9. Shankar K, Zhong Y, Kang P, Blackburn ML, Soares MJ, et al. (2012) RNA-seq analysis of the functional compartments within the rat placentation site. Endocrinology 153: 1999-2011.
10. Wood SH, Craig T, Li Y, Merry B, de Magalhaes JP (2012) Whole transcriptome sequencing of the aging rat brain reveals dynamic RNA changes in the dark matter of the genome. Age.
11. Yu C, Li Y, Holmes A, Szafranski K, Faulkes CG, et al. (2011) RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice. PloS one 6: e26729.
12. Twigger SN, Pruitt KD, Fernandez-Suarez XM, Karolchik D, Worley KC, et al. (2008) What everybody should know about the rat genome and its online resources. Nature genetics 40: 523-527.
13. Atanur SS, Birol I, Guryev V, Hirst M, Hummel O, et al. (2010) The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance. Genome research 20: 791-803.
14. Su Z, Li Z, Chen T, Li QZ, Fang H, et al. (2011) Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Chemical research in toxicology 24: 1486-1493.
15. Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, et al. (2011) Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease. Neurobiology of disease 43: 698-705.
16. Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, et al. (2012) Gene expression profiling of liver cancer stem cells by RNA-sequencing. PloS one 7: e37159.
17. Huang Q, Lin B, Liu H, Ma X, Mo F, et al. (2011) RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PloS one 6: e26168.
18. Sung WK, Zheng H, Li S, Chen R, Liu X, et al. (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nature genetics 44: 765-769.
19. Kensler TW, Roebuck BD, Wogan GN, Groopman JD, (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 120Suppl 1: S28-48.
20. RoC (2011) Aflatoxins. Rep Carcinog: 32-34.
21. Butler WH, Greenblatt M, Lijinsky W, (1969) Carcinogenesis in rats by aflatoxins B1, G1, and B2. Cancer Res 29: 2206-2211.
22. Wogan GN, Newberne PM, (1967) Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res 27: 2370-2376.
23. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, et al. (1998) Activation and detoxication of aflatoxin B1. Mutat Res 402: 121-128.
24. Wogan GN, Kensler TW, Groopman JD (2011) Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess: 1-9.
25. Auerbach SS, Shah RR, Mav D, Smith CS, Walker NJ, et al. (2010) Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicology and applied pharmacology 243: 300-314.
26. Merrick BA, Auerbach SS, Stockton PS, Foley JF, Malarkey DE, et al. (2012) Testing an aflatoxin b1 gene signature in rat archival tissues. Chemical research in toxicology 25: 1132-1144.
27. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols 7: 562-578.
28. Mikkola ML, Thesleff I, (2003) Ectodysplasin signaling in development. Cytokine & growth factor reviews 14: 211-224.
29. Gao W, Mizukawa Y, Nakatsu N, Minowa Y, Yamada H, et al. (2010) Mechanism-based biomarker gene sets for glutathione depletion-related hepatotoxicity in rats. Toxicology and applied pharmacology 247: 211-221.
30. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, et al. (2003) Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. The American journal of pathology 163: 1949-1960.
31. Bhatnagar S, Oler AT, Rabaglia ME, Stapleton DS, Schueler KL, et al. (2011) Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS genetics 7: e1002323.
32. Asselta R, Rimoldi V, Guella I, Solda G, De Cristofaro R, et al. (2010) Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA. Blood 115: 2065-2072.
33. Aninat C, Piton A, Glaise D, Le Charpentier T, Langouet S, et al. (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug metabolism and disposition: the biological fate of chemicals 34: 75-83.
34. Carcagno AL, Ogara MF, Sonzogni SV, Marazita MC, Sirkin PF, et al. (2009) E2F1 transcription is induced by genotoxic stress through ATM/ATR activation. IUBMB life 61: 537-543.
35. Farra R, Dapas B, Pozzato G, Scaggiante B, Agostini F, et al. (2011) Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43: 1006-1014.
36. Shirabe K, Toshima T, Taketomi A, Taguchi K, Yoshizumi T, et al. (2011) Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Liver international: official journal of the International Association for the Study of the Liver 31: 1366-1372.
37. Asim M, Sarma MP, Thayumanavan L, Kar P, (2011) Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population. Clinical biochemistry 44: 1235-1240.
38. Kirk GD, Bah E, Montesano R, (2006) Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27: 2070-2082.
39. Bottomly D, Walter NA, Hunter JE, Darakjian P, Kawane S, et al. (2011) Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays. PloS one 6: e17820.
40. Malone JH, Oliver B, (2011) Microarrays, deep sequencing and the true measure of the transcriptome. BMC biology 9: 34.
41. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
42. Maruo Y, Iwai M, Mori A, Sato H, Takeuchi Y, (2005) Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Current drug metabolism 6: 91-99.
43. Hanioka N, Nonaka Y, Saito K, Negishi T, Okamoto K, et al. (2012) Effect of aflatoxin B1 on UDP-glucuronosyltransferase mRNA expression in HepG2 cells. Chemosphere 89: 526-529.
44. Kobayashi K, Yoshida A, Ejiri Y, Takagi S, Mimura H, et al. (2012) Increased expression of drug-metabolizing enzymes in human hepatocarcinoma FLC-4 cells cultured on micro-space cell culture plates. Drug metabolism and pharmacokinetics.
45. Nayak S, Sashidhar RB, (2010) Metabolic intervention of aflatoxin B1 toxicity by curcumin. Journal of ethnopharmacology 127: 641-644.
46. Kishi M, Emi Y, Sakaguchi M, Ikushiro S, Iyanagi T, (2008) Ontogenic isoform switching of UDP-glucuronosyltransferase family 1 in rat liver. Biochemical and biophysical research communications 377: 815-819.
47. Bajic VB, Tan SL, Christoffels A, Schonbach C, Lipovich L, et al. (2006) Mice and men: their promoter properties. PLoS genetics 2: e54.
48. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, et al. (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nature genetics 38: 626-635.
49. Fang Z, Martin JA, Wang Z, (2012) Statistical methods for identifying differentially expressed genes in RNA-Seq experiments. Cell & bioscience 2: 26.
50. Ding L, Wendl MC, Koboldt DC, Mardis ER, (2010) Analysis of next-generation genomic data in cancer: accomplishments and challenges. Human molecular genetics 19: R188-196.
51. Givan SA, Bottoms CA, Spollen WG, (2012) Computational analysis of RNA-seq. Methods in molecular biology 883: 201-219.
52. Umbreit NT, Gestaut DR, Tien JF, Vollmar BS, Gonen T, et al. (2012) The Ndc80 kinetochore complex directly modulates microtubule dynamics. Proceedings of the National Academy of Sciences of the United States of America 109: 16113-16118.
53. Silins I, Stenius U, Hogberg J, (2004) Induction of preneoplastic rat liver lesions with an attenuated p53 response by low doses of diethylnitrosamine. Archives of toxicology 78: 540-548.
54. Yang Y, Wu F, Ward T, Yan F, Wu Q, et al. (2008) Phosphorylation of HsMis13 by Aurora B kinase is essential for assembly of functional kinetochore. The Journal of biological chemistry 283: 26726-26736.
55. Laws ER Jr, (1991) Conservative surgery and radiation for childhood craniopharyngiomas. Journal of neurosurgery 74: 1025-1026.
56. Reinhold WC, Erliandri I, Liu H, Zoppoli G, Pommier Y, et al. (2011) Identification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instability. PloS one 6: e25991.
57. Ricke RM, van Deursen JM, (2011) Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell cycle 10: 3645-3651.
58. Josse R, Dumont J, Fautrel A, Robin MA, Guillouzo A, (2012) Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicology and applied pharmacology 258: 176-187.
59. Trzos RJ, Petzold GL, Brunden MN, Swenberg JA, (1978) The evaluation of sixteen carcinogens in the rat using the micronucleus test. Mutation research 58: 79-86.
60. Biswas AK, Johnson DG, (2012) Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer research 72: 13-17.
61. Reed CA, Mayhew CN, McClendon AK, Yang X, Witkiewicz A, et al. (2009) RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1. Oncogene 28: 4434-4443.
62. Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, et al. (2010) Regulation of muscle mass by follistatin and activins. Molecular endocrinology 24: 1998-2008.
63. Grusch M, Drucker C, Peter-Vorosmarty B, Erlach N, Lackner A, et al. (2006) Deregulation of the activin/follistatin system in hepatocarcinogenesis. Journal of hepatology 45: 673-680.
64. Ooe H, Chen Q, Kon J, Sasaki K, Miyoshi H, et al. (2012) Proliferation of rat small hepatocytes requires follistatin expression. Journal of cellular physiology 227: 2363-2370.
65. Dean RA, Butler GS, Hamma-Kourbali Y, Delbe J, Brigstock DR, et al. (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Molecular and cellular biology 27: 8454-8465.
66. Szlama G, Kondas K, Trexler M, Patthy L, (2010) WFIKKN1 and WFIKKN2 bind growth factors TGFbeta1, BMP2 and BMP4 but do not inhibit their signalling activity. The FEBS journal 277: 5040-5050.
67. Roberts ME, Magowan L, Hall IP, Johnson SR, (2011) Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 37: 1482-1493.
68. Ferri N, Carragher NO, Raines EW, (2004) Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. The American journal of pathology 164: 1575-1585.
69. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, et al. (2001) Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34: 82-88.
70. Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, et al. (2011) Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 53: 1558-1569.
71. Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, et al. (2011) Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. European journal of cancer 47: 2299-2305.
72. Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA, (2012) Aldehyde dehydrogenases and cell proliferation. Free radical biology & medicine 52: 735-746.
73. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, et al. (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nature genetics 43: 34-41.
74. Dolle L, Best J, Empsen C, Mei J, Van Rossen E, et al. (2012) Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naive mice. Hepatology 55: 540-552.
75. Bisgaard HC, Holmskov U, Santoni-Rugiu E, Nagy P, Nielsen O, et al. (2002) Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. The American journal of pathology 161: 1187-1198.
76. Coban Z, Barton MC, (2012) Integrative genomics: liver regeneration and hepatocellular carcinoma. Journal of cellular biochemistry 113: 2179-2184.
77. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome biology 11: R106.
78. Roberts A, Pimentel H, Trapnell C, Pachter L, (2011) Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27: 2325-2329.
79. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology 28: 511-515.
80. Langmead B, Salzberg SL, (2012) Fast gapped-read alignment with Bowtie 2. Nature methods 9: 357-359.
81. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440-9445.